NL-OMON38231招募中不适用
Study on Working Memory in Adolescents with Autism in the Netherlands (amendment regarding an extension using fMRI) - SWAA
Epilepsiecentrum Kempenhaeghe0 个研究点目标入组 276 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 276
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12 至 99（—）
入选标准
- •For adolescents with HFA:
- •- Age of 12 to 16 years.
- •- Autism disorder or Asperger disorder diagnosis made conform the diagnosis criteria as formulated in the DSM-IV.
- •- A signed informed consent (IC) from the adolescent and the parent/ caregiver.
- •- A high average intelligence conform a HAVO/VWO education level.;For normal control adolescents:;- Age of 12 to 16 years
- •- A signed IC from the adolescent and the parent/ caregiver.
- •- A high average intelligence conform a HAVO/VWO education level.
排除标准
- •For adolescents with HFA:
- •- A diagnosis for other (co-morbid) psychological disorders or psychiatric diseases as formulated in the DSM-IV, such as: attention-deficit and disruptive behaviour disorders, anxiety disorders and mood disorders.
- •- Appearance of additional variables that can influence cognitive functioning such as pathology of the Central Nervous System (CNS), significant hearing impairment, and medicinal treatment for epilepsy.
- •- Use of Methylphenidate. In consultation with the responsible doctor, parent/caregiver and adolescent are asked if they are willing to not take the medicine on the day of the neuropsychological assessment. If all agree, the adolescent may participate in the study.
- •- Inability to speak/understand the Dutch language.
- •- Vision less than +4.5D or - 4.5D.
- •Claustrophobia.
- •Metal implants or other contraindication for MRI.;For normal control adolescents:
- •- A diagnosis for a psychological disorder or psychiatric disease as formulated in the DSM-IV, such as: pervasive developmental disorders, attention-deficit and disruptive behaviour disorders, separation anxiety disorders, selective mutism, reactive attachment disorder of infancy or early childhood, anxiety disorders and mood disorders.
- •- Appearance of additional variables that can influence cognitive functioning such as pathology of the CNS, significant hearing impairment, and medicinal treatment for epilepsy.
- •- Use of Methylphenidate. In consultation with the responsible doctor, parent/caregiver and adolescent are asked if they are willing not to take the medicine on the day of the neuropsychological assessment. If all agree, the adolescent may participate in the study.
- •- Inability to speak/understand the Dutch language.
- •- Vision less than +4.5D or - 4.5D.
- •Claustrophobia.
- •Metal implants or other contraindication for MRI.
研究者
相似试验
尚未招募
不适用
Studie naar het werkgeheugen bij adolescenten met autisme in Nederland.europsychology AdolescentsHigh Functioning Autism Working MemoryNeuropsychologieAdolescentenHoog Functionerend AutismeWerk geheugenNL-OMON23771Epilepsy Centre Kempenhaeghe, Heeze108
已完成
不适用
Working memory in children with attention-deficit/hyperactivity disorder (ADHD): the impact of methylphenidate (MPH)Behavioural disordersMental and Behavioural DisordersHyperkinetic disordersISRCTN52376787HS R&D Regional Programme Register - Department of Health (UK)60
终止
不适用
Improving Working Memory of Children With AutismAutismNCT04209452Arizona State University15
尚未招募
3 期
*Working memory training in children with neuropsychiatric disorders and borderline intellectual functioning*neuropsychiatrische stoornissen en een ontwikkelingsachterstandADHD and Autism spectrum disordersneuropsychiatric disorders10012562NL-OMON36703Karakter100
尚未招募
不适用
Working memory training in children with neuropsychiatric disorders and borderline intellectual functioning.Children with neuropsychiatric disorders and borderline intellectual functioningNL-OMON20558Karakter kinder- en jeugdpsychiatrie100